Hikma Pharmaceuticals Share News (HIK)

BROKER RATINGS SUMMARY: JPMorgan Cuts Merlin To Underweight

BROKER RATINGS SUMMARY: S&P CapIQ Cuts Next To Buy From Strong Buy

Hikma Pharmaceuticals To Sell Ohio-Based Ben Venue Sites To Xellia

LONDON MARKET CLOSE: Stocks End Flat As Investors Await FOMC Minutes

LONDON MARKET MIDDAY: Fed Minutes Awaited For December Rate Hike Clues

WINNERS & LOSERS SUMMARY: Antofagasta, Anglo Up On Goldman Upgrades

LONDON MARKET OPEN: Hikma Shines Amid Downbeat European Markets

LONDON BRIEFING: Hikma And Hunting Gain Amid Weak Early Market

Hikma Says US Regulator Accepts Actions Taken At Portugal Plant

BROKER RATINGS SUMMARY: SocGen Cuts Whitbread To Hold From Buy

Tuesday newspaper share tips: Hikma Pharmaceuticals and Shire under the microscope

(ShareCast News) - Pharmaceuticals were on the newspaper pundits' agenda on Tuesday after Hikma Pharmaceuticals caused a bit of pain. The FTSE 100 company warned on Monday that its generics division is performing below expectations due to slower-than-expected growth in sales for its gout treatment M

BROKER RATINGS SUMMARY: Sells On Barratt, Taylor Wimpey And Persimmon

LONDON MARKET CLOSE: Hikma And Shire Sold Down Amid Firm Market

FTSE 100 movers: Travis Perkins builds gains; Hikma slumps on generics business

(ShareCast News) - London's FTSE 100 was down 0.1% to 6,355.80 at 1445 GMT, as investors weighed up mixed Chinese manufacturing data against better-than-expected UK factory data, with broker notes providing much of the action. Hikma Pharmaceuticals slumped after lowering its guidance for the generic

LONDON MARKET MIDDAY: US Stocks Seen Higher Ahead Of Manufacturing PMI